Summary
This 8-K/A filing details CVS Corporation's acquisition of approximately 700 standalone drugstores and a distribution center from Albertson's, Inc. for $4.0 billion. The acquisition, completed on June 2, 2006, was financed through commercial paper and a $1.0 billion bridge loan. CVS plans to refinance the commercial paper with longer-term debt and expects to monetize a significant portion of the acquired real estate through sale-leaseback transactions in the fourth quarter of 2006 to help retire the bridge loan. The filing also includes extensive financial information related to the acquired "Standalone Drug Business," including carve-out financial statements and pro forma combined financial information. This provides investors with a view of the acquired business's historical performance and its projected impact on CVS's financial statements post-acquisition. The pro forma information highlights the preliminary nature of the purchase price allocation, indicating potential for future adjustments.
Key Highlights
- 1CVS acquired approximately 700 standalone drugstores and a distribution center from Albertson's for $4.0 billion on June 2, 2006.
- 2The acquisition was financed using commercial paper and a $1.0 billion bridge loan, with plans for future refinancing and real estate sale-leaseback transactions.
- 3The filing provides carve-out financial statements for the acquired Albertson's Standalone Drug Business, showing revenues and direct expenses, as well as net assets acquired.
- 4Pro forma combined financial statements are presented, illustrating the potential financial impact of the acquisition on CVS.
- 5The company expects to refinance a portion of commercial paper borrowings with longer-term financing in Q3 2006.
- 6A substantial portion of the acquired real estate is planned for sale-leaseback transactions in Q4 2006 to aid in retiring the bridge loan.
- 7The purchase price allocation in the pro forma statements is preliminary and subject to change.